The Use of the Lower Limit of Normal as a Criterion for COPD Excludes Patients With Increased Morbidity and High Consumption of Health-Care Resources;El uso del límite inferior de la normalidad como criterio de EPOC excluye pacientes con elevada morbilidad y alto consumo de recursos sanitarios

Archivos de Bronconeumologia

Volumn 48, Issue 7, 2012, Pages 223-228

  Izquierdo Alonso, José Luis ^a,b   De Lucas Ramos, Pilar ^a,b   Rodríguez Glez Moro, José Miguel ^a,b  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Diagnosis; Global initiative on obstructive lung disease; Lower limit of normal

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; EMERGENCY HEALTH SERVICE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GOLD CRITERIA; HEALTH CARE PLANNING; HUMAN; LOWER LIMIT OF NORMAL; MORBIDITY; PRESCRIPTION; PREVALENCE; ADULT; CLINICAL ASSESSMENT TOOL; EMERGENCY WARD; FEMALE; HEALTH CARE UTILIZATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; RESPIRATORY TRACT DISEASE ASSESSMENT;

EID: 85047698436     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2012.05.002     Document Type: Article

References (28)

1. Peces-Barba G., Barberà J.A., Agustí A., Casanova C., Casas A., Izquierdo J.L., et al. Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. Arch Bronconeumol 2008, 44:271-281.
2. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management and prevention of COPD [consultado 2007]. Disponible en: http://www.goldcopd.com/.
3. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946.
4. Celli B.R., Halbert R.J., Isonaka S., Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003, 22:268-273.
5. Roberts S.D., Farber M.O., Knox K.S., Phillips G.S., Bhatt N.Y., Mastronarde J.G., et al. FEV1/FVC of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006, 130:200-206.
6. Hardie J.A., Buist A.S., Vollmer W.M., Ellingsen I., Bakke P.S., Mørkve O. Risk of overdiagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002, 20:1117-1122.
7. Enright P. Does screening for COPD by primary care physicians have the potential to cause more harm than good?. Chest 2006, 129:833-834.
8. Vaz Fragoso C.A., Concato J., McAvay G., Van Ness P.H., Rochester C.L., Yaggi H.K., et al. Chronic obstructive pulmonary disease in older persons: a comparison of two spirometric definitions. Respir Med 2010, 104:1189-1196.
9. Pellegrino R., Viegi G., Brusasco V., Crapo R.O., Burgos F., Casaburi R., et al. Interpretative strategies for lung function tests. Eur Respir J 2005, 26:948-968.
10. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., Yernault J.C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993, 6(Suppl 16):5-40.
11. Lucas Ramos P., Izquierdo Alonso J.L., Rodríguez González-Moro J.M., Bellón Cano J.M., Ancochea Bermúdez J., Calle-Rubio M., et al. Asociación de factores de riesgo cardiovascular y EPOC. Resultados de un estudio epidemiológico (estudio ARCE). Arch Bronconeumol 2008, 238:233-238.
12. Scanlon P.D., Connett J.E., Waller L.A., Altose M.D., Bailey W.C., Buist A.S. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000, 161:381-390.
13. Pinto-Plata V.M., Celli-Cruz R.A., Vassaux C., Torre-Bouscoulet L., Mendes A., Rassulo J., et al. Differences in cardiopulmonary exercise test results by American Thoracic Society/European Respiratory Society - Global Initiative for Chronic Obstructive Lung Disease stage categories and gender. Chest 2007, 132:1204-1211.
14. Enright P.L. GOLD stage I is not a COPD risk factor. Thorax 2007, 62:1107-1109.
15. Roche N., Dalmay F., Perez T., Kuntz C., Vergnenegre A., Neukirche F., et al. Impact of chronic airflow obstruction in a working population. Eur Respir J 2008, 31:1227-1233.
16. Ofir D., Laveneziana P., Webb K.A., Lam Y.M., O'Donnell D.E. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 177:622-629.
17. Mannino D.M., Díaz-Guzmán E. Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality. Chest 2012, 141:73-80.
18. Vollmer W.M., Gislason T., Burney P., Enright P.L., Gulsvik A., Kocabas A., et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009, 34:588-597. for the BOLD Collaborative Research Group.
19. Mannino D.M., Buist A.S., Volmer W.M. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?. Thorax 2007, 62:237-241.
20. Barr R.G., Celli B.R., Mannino D.M., Petty T., Rennard S.I., Sciurba F.C., et al. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med 2009, 122:348-355.
21. Sin D.D., Anthonisen N.R., Soriano J.B., Agusti A.G. Mortality in COPD: Role of comorbidities. Eur Respir J 2006, 28:1245-1257.
22. Fabbri L.M., Luppi F., Beghe B., Rabe K.F. Complex chronic comorbidities of COPD 2008, 31:204-212.
23. Wan S., Hokanson J.E., Murphy J.R., Regan E.A., Make B.J., Lynch D.A., et al. Clinical and Radiographic Predictors of GOLD - Unclassified Smokers in the COPDGene Study. Am J Respir Crit Care Med Vol 2011, 184:57-63.
24. Soriano J.B., Ancochea J., Miravitlles M., García-Río F., Duran E., Muñoz L., et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur Respir J 2010, 36:758-765.
25. Izquierdo J.L., de Lucas P., Rodríguez J.M., Pons S. Características clínicas de dos poblaciones diagnosticadas de EPOC por criterios espirométricos GOLD o por el límite inferior de la normalidad. Rev Patol Resp 2010, 13:159-164.
26. Punturieri A., Croxton T.L., Weinmann G.G., Kiley J.P. Chronic obstructive pulmonary disease: a view from the NHLBI. Am J Respir Crit Care Med 2008, 178:441-443.
27. García-Rio F., Soriano J.B., Miravitlles M., Muñoz L., Duran-Tauleria E., Sánchez G., et al. Overdiagnosing subjects with COPD using the 0.7 fixed ratio: correlation with a poor health-related quality of life. Chest 2011, 139:1072-1080.
28. Izquierdo J.L., Rodríguez J.M., de Lucas P., Martín Centeno A., Gobartt E. ¿Ha cambiado el manejo de la EPOC en España? Resultados de un estudio multicéntrico comunitario (VICE). Rev Clin Esp 2008, 208:18-25.